ORX-301

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameORX-301
Drug Alias NameBeta-cyclodextrin based polymer prodrug (Oraxion Therapeutics)Polymer prodrug (Oraxion Therapeutics)ORX-301
ClassificationSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGlomerulosclerosis, Focal SegmentalNiemann-Pick Disease, Type C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOraxion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOraxion Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGlomerulosclerosis, Focal SegmentalNiemann-Pick Disease, Type C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A